A vaccine that may prevent HIV has been given the green light by the U.S. Food and Drug Administration to begin clinical trials in humans, according to Canadian researchers.
The announcement was made on the campus of the University of Western Ontario in London, Ont.
The vaccine stimulated a strong immune response in early testing and appears to have no adverse effects, according to the researchers.
(READ the story from CBS News)